CIMIT Program Leaders:

Biodefense and Sepsis
Jeffrey Gelfand, MD
jgelfand@partners.com
617-726-1796

Biomaterials and Tissue Engineering
(Co-Program Leaders)
Jeffrey Borenstein, PhD
jborenstein@draper.com
617-258-1686

Joseph Vacanti, MD
jvacanti@partners.org
617-724-1725

Cardiovascular Disease
(Co-Program Leaders)
Thomas Brady, MD
tom@nmr.mgh.harvard.edu
617-726-8313

Ahmed Tawakol, MD
atawakol@partners.org

Clinical Systems Innovation
David Judge, MD
djudge@partners.org

Global Health Initiative
Kristian Olson, MD, MPH
krolson@partners.org
617-643-0602

Image Guided Therapy
(Co-Program Leaders)
Ferenc Jolesz, MD
jolesz@bwh.harvard.edu

Ron Kikinis, MD
kikinis@bwh.harvard.edu

Minimally Invasive Surgery
David Rattner, MD
David Rattner via CIMIT.org

Neurotechnology
Steven Schachter, MD
sschacht@bidmc.harvard.edu

New Initiatives
Kirby Vosburgh, PhD
kvosburgh@partners.org
617-643-3839

Optical Diagnostics
Gary Tearney, MD, PhD
gtearney@partners.org
617-724-2979

Simulation
Steve Dawson, MD
dawson.steven
@mgh.harvard.edu

617-768-8781

Trauma & Casualty Care
George Velmahos, MD, PhD
gvelmahos@partners.org

 

2008 GUIDELINES FOR PROGRAM LEADERS

Introduction
Programs provide important structure for CIMIT. By bringing together investigators within a field, CIMIT’s Programs enhance interaction among investigators, and concentrate local activities for national recognition. Program Leaders are charged with cultivating investigators, nurturing and managing Program activities and sharing and disseminating the results.

The General Requirements for Program Leaders are:

Program Leader Expectations
Program Leaders have diverse backgrounds and a range of non-CIMIT commitments. Accordingly CIMIT seeks different contributions (deliverables) from Program Leaders. In return for financial support, Programs Leaders agree to meet the expectations described as major deliverables plus four of the additional activities listed below. Funding support for 2008 Programs Leaders will be based on 2007 performance in these categories:

Major Deliverables are:

Additional Activities are:

Program Research Content
1. Individual research projects fall within a Program area by mutual consent of Program Leader and the Program Management Committee, K. Vosburgh, Chair. The projects may be initiated from several sources:

2. In order for CIMIT funds to be committed to a project regardless of the source of the project, it must be approved via the CIMIT review process.

3. Size of Programs:

Program Leaders as Investigators
A Program Leader may also be an investigator on CIMIT-supported research projects. In this case the percentage of effort proposed for research would be reviewed by the CIMIT peer review process. Therefore, a Program Leader could receive CIMIT salary support in two ways:

1. As a Program Leader with justified percentage of effort for the guidance and integration activities described above

2. As an investigator with percentage of research effort as approved by peer review